Home > Healthcare & Medical Devices > Demulcent Eye Drops Market

Demulcent Eye Drops Market Size by Active Pharmaceutical Ingredient Type (Cellulose Derivatives, Dextran 70, Polyols, Polymers), By Drug formulation (Preservative Based, Non-Preservative Based), Medication Type, Distribution Channel & Forecast, 2022 - 2030

  • Report ID: GMI5351
  • Published Date: Sep 2022
  • Report Format: PDF

Industry Overview

Demulcent Eye Drops Market size was worth more than USD 1.8 billion in 2021 and is expected to grow at a CAGR of more than 6% through 2030. Easy product accessibility and increased availability will push industry growth.

Demulcent Eye Drops Market

To get more details on this report: Request Free Sample PDF

Growing cases of various eye disorders across the world is the primary factor propelling the market expansion. Recent data reveals that dry eye disease (DED) affects around 5% adult Americans. Notably, DED leads to numerous complications such as microaneurysm, optic nerve injury, and retinal thickness. Increase in instances of dry eye disease is one of the main factors that will boost demand for demulcent eye drops.  Additionally, higher pervasiveness of ocular ailments across developing nations, especially among geriatric population will augment the demulcent eye drops market outlook.

Side-effects of demulcent eye drops solutions to complement industry landscape

One of the key factors preventing the business from growing is the fact that demulcent eye drops, which are readily available over-the-counter, have a variety of negative effects. These eye drops are preserved using ingredients including purite, EDTA, and BAK to maintain pH level of tear film. Excessive or incorrect usage of such medications may cause adverse reactions such as allergies and ocular toxicity. The looming chances of discontinuation of certain ocular eye drops with preservatives may restrain the market growth.

Increasing incidence of digital eye strain to propel demand for polyols

Demulcent Eye Drops Market , by API Type

To get more details on this report: Request Free Sample PDF

The demulcent eye drops market is divided into polyols, dextran 70, polymers, cellulose derivatives, and others, based on active pharmaceutical ingredient types. The polyols segment crossed USD 550 million in 2021. The cases of digital eye strain is rising as a result of the growing usage of electronic gadgets. Furthermore, a notable rise in retinal diseases and eye treatments has stimulated segment share.

Growing safety concerns to foster adoption of non-preservative-based products

Depending on drug formulation, the demulcent eye drops market is segmented into preservative based and non-preservative-based products. The non-preservative-based segment is set to surpass USD 1 billion by 2030. Preservatives such as sodium chlorite, benzalkonium chloride (BAK), etc. are used in eye drop formulations which are harmful at times.

The non-preservative-based demulcent eye drops segment is expected to develop in the forthcoming years owing to consumer preference for product due to the growing awareness of the eye-health risks caused by preservatives.

Easy product availability and accessibility to bolstering OTC segment revenue

The market is categorized into over the counter (OTC) and prescriptions, as per medication type. The OTC segment exceeded USD 1 billion in 2021. Over-the-counter medications are the ones that may be purchased without a prescription, ensuring easier access to pharmaceuticals. Increased availability and accessibility of demulcent eye drops to the general public through OTC is impelling the segment demand.

Cost-effectiveness to increase product sales through retail pharmacies

Demulcent Eye Drops Market, by Distribution Channel

To get more details on this report: Request Free Sample PDF

In terms of distribution channel, worldwide demulcent eye drops market is categorized into retail pharmacies, online pharmacies, and hospital pharmacies. The retail pharmacies segment held more than 50% business share in 2021 and is projected to record significant growth rate over the study period. The availability of affordable demulcent eye drops at retail medical stores and the rising acceptance of over-the-counter products are giving push to the industry value.

Growing prevalence of DED in Europe to drive regional market demand

Europe demulcent eye drops market is anticipated to surpass USD 875 million by 2030. This is due to growing elderly population base and the significant increase in the patients suffering from dry eye disease in the European nations. The product demand will soar in the coming years, resulting from the consequences of DED such as corneal ulcers, vision loss, and decreased quality of life.

Innovative launches to define competitive landscape of the market

Firms like Johnson and Johnson Services Inc., Alcon Inc., OASIS Medical, Allegan (AbbVie Inc.), Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co. Ltd., Bausch Health Companies Inc., Aurolab, Otsuka Pharmaceutical Co.,Ltd., Sentiss Pharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., and URSAPHARM Arzneimittel GmbH are the major competitors in the demulcent eye drops market.

In order to establish a strong market position, the manufacturers are strategically focusing on creating innovative solutions to meet the requirements of the customers. For instance, in January 2022, Systane Complete Preservative-Free Lubricant Eye Drops was made available in Europe by Alcon. This strategy widened Alcon's footprint in the massive and rapidly expanding artificial tears industry, generating sales worth over USD 1 billion annually.

Impact of COVID-19 on demulcent eye drops market trends

The COVID-19 outbreak negatively affected almost every industry and organization, irrespective of size, plummeting the global economy. Due to the lack of both critical and non-essential medical supplies, there was a turmoil in the medical sector. The disruption of the supply chain impacted the production and shipping of demulcent eye drops, hampering the industry growth. However, growing sales of OTC demulcent eye drops, in tandem with shifting consumer preference for purchasing through online pharmacies will aid the global market to recover and grow in the coming years.

The demulcent eye drops market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2030, for the following segments:

Click here to Buy Section of this Report

By Active Pharmaceutical Ingredient Type

  • Cellulose Derivatives
  • Dextran 70
  • Polyols
  • Polymers
  • Others

By Drug Formulation

  • Preservative Based
  • Non-Preservative Based

By Medication Type

  • Over-the-counter (OTC)
  • Prescription

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Others


Authors: Rupali Swain, Subodh Kharad

Frequently Asked Questions (FAQ) :

The global market size for demulcent eye drop was valued at over USD 1.8 billion in 2021 and is predicted to rise at a CAGR of over 6% through 2030, owing to an increase in the incidence rate of eye ailments worldwide.

The polyols segment was valued over USD 550 million in 2021 and will exhibit a significant growth during the forecast period, owing to its usage for treatment of digital eye strain, retinal diseases, and other eye conditions.

The non-preservative-based formulation segment held a sizable market share in 2021 and is projected to surpass USD 1 billion by 2030, owing to its increasing usage resulting from growing awareness of the eye-health risks caused by preservatives.

Top enterprises such as Johnson and Johnson Services Inc., Alcon Inc., OASIS Medical, Allegan (AbbVie Inc.), Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co. Ltd., Bausch Health Companies Inc., Aurolab, and others form the competitive landscape of the global demulcent eye drops market.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 12
  • Tables & Figures: 238
  • Countries covered: 17
  • Pages: 240
Inquiry Before Buying

Budget constraints? Get in touch with us for special pricing

Request Discount